Patients to be given cannabis in pain trial
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Cannabis pills will be given to 400 NHS patients in an experiment to see if the drug alleviates pain after surgery.
The patients will be split into four groups at 36 hospitals. Some will take a pill containing cannabis extract, others a pill containing the drug's active ingredient, tetrahydrocannabinol, and the rest a painkiller or a placebo. The patients will be given the pills after surgery once they have stopped using morphine and will be monitored over six hours.
Dr Anita Holdcroft from Imperial College London, who is running the £500,000 trial from the Chelsea and Westminster Hospital, said anecdotal evidence suggested cannabis could relieve pain but doctors needed to assess the evidence scientifically and compare it with existing medications.
The trial, funded by the Medical Research Council (MRC), was launched earlier this year but difficulties in recruiting volunteers prompted Dr Holdcroft to appeal for people to come forward yesterday.
Medicines derived from the cannabis plant are being tested by drug companies around the world as treatments for stiffness, tremor, weak bladder, loss of appetite and high blood pressure, as well as pain.
Positive findings from a £1.2m trial of cannabis in patients with multiple sclerosis, also funded by the MRC, are expected later this month. The study, the largest in the world, is expected to show cannabis helps to reduce muscle spasms and improve bladder control.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments